Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands Reach into Preclinical Trials, Alternative Medicine
Dedicated to the health-conscious consumer Expanded preclinical trial pipeline by entering into definitive agreement to acquire Tassili Life Sciences Corp Expanding brand into alternative medicine by entering into a definitive agreement to acquire Novoformulations Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to the distribution of artisanal medicinal mushroom-infused products, is expanding its portfolio with the health-conscious consumer in mind. SHRM recently entered into a definitive agreement to acquire two separate companies: Tassili Life Sciences Corp. and Novoformulations, a specialty biotechnology company. SHRM recently announced it has expanded its preclinical trial pipeline by entering into…